28097611|t|Assessing nitrous oxide effect using electroencephalographically -based depth of anesthesia measures cortical state and cortical input
28097611|a|Existing electroencephalography (EEG) based depth of anesthesia monitors cannot reliably track sedative or anesthetic states during n-methyl-D-aspartate (NMDA) receptor antagonist based anesthesia with ketamine or nitrous oxide (N2O). Here, a physiologically -motivated depth of anesthesia monitoring algorithm based on autoregressive-moving-average (ARMA) modeling and derivative measures of interest, Cortical State (CS) and Cortical Input (CI), is retrospectively applied in an exploratory manner to the NMDA receptor antagonist N2O, an adjuvant anesthetic gas used in clinical practice. Composite Cortical State (CCS) and Composite Cortical State distance (CCSd), two new modifications of CS, along with CS and CI were evaluated on electroencephalographic (EEG) data of healthy control individuals undergoing N2O inhalation up to equilibrated peak gas concentrations of 20, 40 or 60% N2O / O2. In particular, CCSd has been devised to vary consistently for increasing levels of anesthetic concentration independent of the anesthetic's microscopic mode of action for both N2O and propofol. The strongest effects were observed for the 60% peak gas concentration group. For the 50-60% peak gas levels, individuals showed statistically significant reductions in responsiveness compared to rest, and across the group CS and CCS increased by 39 and 42%, respectively, while CCSd was found to decrease by 398%. On the other hand a clear conclusion regarding the changes in CI could not be reached. These results indicate that, contrary to previous depth of anesthesia monitoring measures, the CS, CCS, and especially CCSd measures derived from frontal EEG are potentially useful for differentiating gas concentration and responsiveness levels in people under N2O. On the other hand, determining the utility of CI in this regard will require larger sample sizes and potentially higher gas concentrations. Future work will assess the sensitivity of CS -based and CI measures to other anesthetics and their utility in a clinical environment.
28097611	0	9	Assessing	T058	C0184514
28097611	10	23	nitrous oxide	T121,T123,T197	C0028215
28097611	24	30	effect	T080	C1280500
28097611	37	64	electroencephalographically	T060	C0013819
28097611	72	91	depth of anesthesia	T033	C0474710
28097611	92	100	measures	T081	C0079809
28097611	101	109	cortical	T023	C0007776
28097611	110	115	state	T170	C0918012
28097611	120	128	cortical	T023	C0007776
28097611	129	134	input	T170	C0918012
28097611	144	166	electroencephalography	T060	C0013819
28097611	168	171	EEG	T060	C0013819
28097611	179	198	depth of anesthesia	T033	C0474710
28097611	199	207	monitors	T058	C0184514
28097611	230	238	sedative	T121	C0036557
28097611	242	252	anesthetic	T121	C0002932
28097611	253	259	states	T080	C0348080
28097611	267	314	n-methyl-D-aspartate (NMDA) receptor antagonist	T121	C3536824
28097611	321	331	anesthesia	T061	C0002903
28097611	337	345	ketamine	T109,T121	C0022614
28097611	349	362	nitrous oxide	T121,T123,T197	C0028215
28097611	364	367	N2O	T121,T123,T197	C0028215
28097611	378	393	physiologically	T169	C0205463
28097611	405	424	depth of anesthesia	T033	C0474710
28097611	425	435	monitoring	T058	C1283169
28097611	436	445	algorithm	T170	C0002045
28097611	455	500	autoregressive-moving-average (ARMA) modeling	T170	C3161035
28097611	538	546	Cortical	T023	C0007776
28097611	547	552	State	T170	C0918012
28097611	554	556	CS	T170	C0918012
28097611	562	570	Cortical	T023	C0007776
28097611	571	576	Input	T170	C0918012
28097611	578	580	CI	T170	C0918012
28097611	586	601	retrospectively	T062	C0035363
28097611	616	627	exploratory	T169	C1292732
28097611	642	666	NMDA receptor antagonist	T121	C3536824
28097611	667	670	N2O	T121,T123,T197	C0028215
28097611	675	698	adjuvant anesthetic gas	T121	C0002904
28097611	707	724	clinical practice	T169	C0205245
28097611	726	750	Composite Cortical State	T170	C0918012
28097611	752	755	CCS	T170	C0918012
28097611	761	794	Composite Cortical State distance	T170	C0918012
28097611	796	800	CCSd	T170	C0918012
28097611	811	824	modifications	T033	C3840684
28097611	828	830	CS	T170	C0918012
28097611	843	845	CS	T170	C0918012
28097611	850	852	CI	T170	C0918012
28097611	858	867	evaluated	T058	C0220825
28097611	871	894	electroencephalographic	T060	C0013819
28097611	896	899	EEG	T060	C0013819
28097611	901	905	data	T078	C1511726
28097611	909	936	healthy control individuals	T080	C2986479
28097611	948	951	N2O	T121,T123,T197	C0028215
28097611	952	962	inhalation	T040	C0004048
28097611	969	981	equilibrated	T081	C1547026
28097611	982	1005	peak gas concentrations	T081	C0457929
28097611	1023	1026	N2O	T121,T123,T197	C0028215
28097611	1029	1031	O2	T121,T123,T196	C0030054
28097611	1048	1052	CCSd	T170	C0918012
28097611	1095	1105	increasing	T081	C0205217
28097611	1106	1112	levels	T080	C0441889
28097611	1116	1140	anesthetic concentration	T033	C0474704
28097611	1141	1155	independent of	T169	C0332291
28097611	1160	1172	anesthetic's	T121	C0002932
28097611	1173	1184	microscopic	T080	C0205288
28097611	1185	1199	mode of action	T169	C1524059
28097611	1209	1212	N2O	T121,T123,T197	C0028215
28097611	1217	1225	propofol	T109,T121	C0033487
28097611	1241	1248	effects	T080	C1280500
28097611	1275	1297	peak gas concentration	T081	C0457929
28097611	1298	1303	group	T098	C1257890
28097611	1320	1335	peak gas levels	T080	C0441889
28097611	1337	1348	individuals	T098	C0237401
28097611	1356	1381	statistically significant	T081	C0237881
28097611	1382	1392	reductions	T061	C0441610
28097611	1396	1410	responsiveness	T033	C3261286
28097611	1411	1419	compared	T052	C1707455
28097611	1423	1427	rest	T056	C0035253
28097611	1444	1449	group	T098	C1257890
28097611	1450	1452	CS	T170	C0918012
28097611	1457	1460	CCS	T170	C0918012
28097611	1461	1470	increased	T081	C0205217
28097611	1506	1510	CCSd	T170	C0918012
28097611	1524	1532	decrease	T081	C0547047
28097611	1568	1578	conclusion	T078	C1707478
28097611	1604	1606	CI	T170	C0918012
28097611	1635	1642	results	T169	C1274040
28097611	1658	1666	contrary	T082	C1521805
28097611	1679	1698	depth of anesthesia	T033	C0474710
28097611	1699	1709	monitoring	T058	C1283169
28097611	1710	1718	measures	T081	C0079809
28097611	1724	1726	CS	T170	C0918012
28097611	1728	1731	CCS	T170	C0918012
28097611	1748	1752	CCSd	T170	C0918012
28097611	1753	1761	measures	T081	C0079809
28097611	1762	1769	derived	T080	C1441547
28097611	1775	1782	frontal	T082	C0205123
28097611	1783	1786	EEG	T060	C0013819
28097611	1791	1802	potentially	T080	C3245505
28097611	1830	1847	gas concentration	T081	C0457929
28097611	1852	1873	responsiveness levels	T033	C3261286
28097611	1877	1883	people	T098	C0027361
28097611	1890	1893	N2O	T121,T123,T197	C0028215
28097611	1930	1937	utility	T169	C0457083
28097611	1941	1943	CI	T170	C0918012
28097611	1972	1978	larger	T081	C0549177
28097611	1979	1991	sample sizes	T081	C0242618
28097611	1996	2007	potentially	T080	C3245505
28097611	2008	2014	higher	T080	C0205250
28097611	2015	2033	gas concentrations	T081	C0457929
28097611	2052	2058	assess	T058	C0184514
28097611	2063	2074	sensitivity	T081	C0036667
28097611	2078	2080	CS	T170	C0918012
28097611	2092	2094	CI	T170	C0918012
28097611	2095	2103	measures	T081	C0079809
28097611	2113	2124	anesthetics	T121	C0002932
28097611	2135	2142	utility	T169	C0457083
28097611	2148	2156	clinical	T073,T093	C0442592
28097611	2157	2168	environment	T082	C0014406